200 related articles for article (PubMed ID: 37122075)
1. Diverse but desolate landscape of gut microbial azoreductases: A rationale for idiopathic IBD drug response.
Simpson JB; Sekela JJ; Carry BS; Beaty V; Patel S; Redinbo MR
Gut Microbes; 2023; 15(1):2203963. PubMed ID: 37122075
[TBL] [Abstract][Full Text] [Related]
2. Gut Microbiome-Wide Search for Bacterial Azoreductases Reveals Potentially Uncharacterized Azoreductases Encoded in the Human Gut Microbiome.
Braccia DJ; Minabou Ndjite G; Weiss A; Levy S; Abeysinghe S; Jiang X; Pop M; Hall B
Drug Metab Dispos; 2023 Jan; 51(1):142-153. PubMed ID: 36116790
[TBL] [Abstract][Full Text] [Related]
3. Two-Sample Mendelian Randomization Analysis Investigates Causal Associations Between Gut Microbial Genera and Inflammatory Bowel Disease, and Specificity Causal Associations in Ulcerative Colitis or Crohn's Disease.
Liu B; Ye D; Yang H; Song J; Sun X; Mao Y; He Z
Front Immunol; 2022; 13():921546. PubMed ID: 35860271
[TBL] [Abstract][Full Text] [Related]
4. Gut microbiota in mucosa and feces of newly diagnosed, treatment-naïve adult inflammatory bowel disease and irritable bowel syndrome patients.
Čipčić Paljetak H; Barešić A; Panek M; Perić M; Matijašić M; Lojkić I; Barišić A; Vranešić Bender D; Ljubas Kelečić D; Brinar M; Kalauz M; Miličević M; Grgić D; Turk N; Karas I; Čuković-Čavka S; Krznarić Ž; Verbanac D
Gut Microbes; 2022; 14(1):2083419. PubMed ID: 35695669
[TBL] [Abstract][Full Text] [Related]
5. Overrepresentation of Enterobacteriaceae and
Khorsand B; Asadzadeh Aghdaei H; Nazemalhosseini-Mojarad E; Nadalian B; Nadalian B; Houri H
Front Cell Infect Microbiol; 2022; 12():1015890. PubMed ID: 36268225
[TBL] [Abstract][Full Text] [Related]
6. Colon-specific prodrugs of 4-aminosalicylic acid for inflammatory bowel disease.
Dhaneshwar SS
World J Gastroenterol; 2014 Apr; 20(13):3564-71. PubMed ID: 24707139
[TBL] [Abstract][Full Text] [Related]
7. Dynamics of metatranscription in the inflammatory bowel disease gut microbiome.
Schirmer M; Franzosa EA; Lloyd-Price J; McIver LJ; Schwager R; Poon TW; Ananthakrishnan AN; Andrews E; Barron G; Lake K; Prasad M; Sauk J; Stevens B; Wilson RG; Braun J; Denson LA; Kugathasan S; McGovern DPB; Vlamakis H; Xavier RJ; Huttenhower C
Nat Microbiol; 2018 Mar; 3(3):337-346. PubMed ID: 29311644
[TBL] [Abstract][Full Text] [Related]
8. Gut microbial metabolism of 5-ASA diminishes its clinical efficacy in inflammatory bowel disease.
Mehta RS; Mayers JR; Zhang Y; Bhosle A; Glasser NR; Nguyen LH; Ma W; Bae S; Branck T; Song K; Sebastian L; Pacheco JA; Seo HS; Clish C; Dhe-Paganon S; Ananthakrishnan AN; Franzosa EA; Balskus EP; Chan AT; Huttenhower C
Nat Med; 2023 Mar; 29(3):700-709. PubMed ID: 36823301
[TBL] [Abstract][Full Text] [Related]
9. Using Theory To Extend the Scope of Azobenzene Drugs in Chemotherapy: Novel Combinations for a Specific Delivery.
Cerón-Carrasco JP; Jacquemin D
ChemMedChem; 2021 Jun; 16(11):1764-1774. PubMed ID: 33619857
[TBL] [Abstract][Full Text] [Related]
10. Analysis of endoscopic brush samples identified mucosa-associated dysbiosis in inflammatory bowel disease.
Nishino K; Nishida A; Inoue R; Kawada Y; Ohno M; Sakai S; Inatomi O; Bamba S; Sugimoto M; Kawahara M; Naito Y; Andoh A
J Gastroenterol; 2018 Jan; 53(1):95-106. PubMed ID: 28852861
[TBL] [Abstract][Full Text] [Related]
11. Intestinal Taxa Abundance and Diversity in Inflammatory Bowel Disease Patients: An Analysis including Covariates and Confounders.
Teofani A; Marafini I; Laudisi F; Pietrucci D; Salvatori S; Unida V; Biocca S; Monteleone G; Desideri A
Nutrients; 2022 Jan; 14(2):. PubMed ID: 35057440
[TBL] [Abstract][Full Text] [Related]
12. Assessment of the prevalence of infection with Helicobacter pylori in patients with inflammatory bowel disease.
Pearce CB; Duncan HD; Timmis L; Green JR
Eur J Gastroenterol Hepatol; 2000 Apr; 12(4):439-43. PubMed ID: 10783998
[TBL] [Abstract][Full Text] [Related]
13. Long-term dietary patterns are associated with pro-inflammatory and anti-inflammatory features of the gut microbiome.
Bolte LA; Vich Vila A; Imhann F; Collij V; Gacesa R; Peters V; Wijmenga C; Kurilshikov A; Campmans-Kuijpers MJE; Fu J; Dijkstra G; Zhernakova A; Weersma RK
Gut; 2021 Jul; 70(7):1287-1298. PubMed ID: 33811041
[TBL] [Abstract][Full Text] [Related]
14. Microbial imbalance in inflammatory bowel disease patients at different taxonomic levels.
Alam MT; Amos GCA; Murphy ARJ; Murch S; Wellington EMH; Arasaradnam RP
Gut Pathog; 2020; 12():1. PubMed ID: 31911822
[TBL] [Abstract][Full Text] [Related]
15. Comparison of outcomes of continuation/discontinuation of 5-aminosalicylic acid after initiation of anti-tumor necrosis factor-alpha therapy in patients with inflammatory bowel disease.
Choi YI; Kim TJ; Park DK; Chung JW; Kim KO; Kwon KA; Kim YJ
Int J Colorectal Dis; 2019 Oct; 34(10):1713-1721. PubMed ID: 31471699
[TBL] [Abstract][Full Text] [Related]
16. Transplantation of bacteriophages from ulcerative colitis patients shifts the gut bacteriome and exacerbates the severity of DSS colitis.
Sinha A; Li Y; Mirzaei MK; Shamash M; Samadfam R; King IL; Maurice CF
Microbiome; 2022 Jul; 10(1):105. PubMed ID: 35799219
[TBL] [Abstract][Full Text] [Related]
17. Gut microbiota analyses of inflammatory bowel diseases from a representative Saudi population.
Alsulaiman RM; Al-Quorain AA; Al-Muhanna FA; Piotrowski S; Kurdi EA; Vatte C; Alquorain AA; Alfaraj NH; Alrezuk AM; Robinson F; Dowdell AK; Alamri TA; Hamilton L; Lad H; Gao H; Gandla D; Keating BJ; Meng R; Piening B; Al-Ali AK
BMC Gastroenterol; 2023 Jul; 23(1):258. PubMed ID: 37507685
[TBL] [Abstract][Full Text] [Related]
18. Microbial Dynamics in Newly Diagnosed and Treatment Naïve IBD Patients in the Mediterranean.
Rausch P; Ellul S; Pisani A; Bang C; Tabone T; Marantidis Cordina C; Zahra G; Franke A; Ellul P
Inflamm Bowel Dis; 2023 Jul; 29(7):1118-1132. PubMed ID: 36735955
[TBL] [Abstract][Full Text] [Related]
19. Metaproteomics of fecal samples of Crohn's disease and Ulcerative Colitis.
Lehmann T; Schallert K; Vilchez-Vargas R; Benndorf D; Püttker S; Sydor S; Schulz C; Bechmann L; Canbay A; Heidrich B; Reichl U; Link A; Heyer R
J Proteomics; 2019 Jun; 201():93-103. PubMed ID: 31009805
[TBL] [Abstract][Full Text] [Related]
20. Serological profiling of Crohn's disease and ulcerative colitis patients reveals anti-microbial antibody signatures.
Shome M; Song L; Williams S; Chung Y; Murugan V; Park JG; Faubion W; Pasha SF; Leighton JA; LaBaer J; Qiu J
World J Gastroenterol; 2022 Aug; 28(30):4089-4101. PubMed ID: 36157118
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
